Advertising and health
- Focused on healthcare ? Use Twitter
- Prevent cancer by examining your skin thoroughly
- Foursquare can be healthy
- IBM makes its technology more human
- Valentín’s Four Teas
- Crowdsourcing: + communication + health
- La ciencia consigue penetrar en la mente de los (rat...
- An Interactive Approach to Improving Childrens’ Heal...
- Education for health…
- anatomy mad
- More items from this source »
Dose of Digital
- 16 Social Media Precedent Setters
- Dose of Digital Heading to SXSW…Maybe
- Digital Alert and Reco: FDA Warns Novartis Over Face...
- 4 Mistakes You Make By Playing Not to Lose in Social...
- How One Pharma Company Successfully Manages YouTube
- Why Your Facebook Page Doesn’t Exist
- 7 Links to Read from Dose of Digital
- An Award for Dose of Digital…Thanks
- More items from this source »
ePharma Rx
- Upcoming Digital Pharma Conferences
- Pharma Social Media: Live and Learn
- FDA WidgetGate: Implications and Recommendations
- FDA’s 1st Social Sharing Spanking: Was it the Medium...
- Customer Service is the New Marketing is the New Cus...
- On Being Creative in a Regulated World
- Where Shiny Object Meets Results
- Tips for 2011 Planning Season
- More items from this source »
Eye on FDA
- Qualitative Look at DDMAC NOV and Warning Letters Du...
- When Does FDA Extend a PDUFA Date?
- Slogging Through Blogging as a Highly Regulated Indu...
- The Battle of the Bulge - New Guidances from FDA on ...
- The Case of the Missing Advisory Committee Transcrip...
- Weekly Roundup - 08/20/10
- What Type Meeting Are You? A B or C?
- Roche Publishes Social Media Principles
- A Look at FDA's Transparency
- More Warning and NOV Letters to Come?
- More items from this source »
Pharma Strategy Blog
- Diabetes drug may protect against cancer
- LKB1 is a master kinase in cancer
- What causes resistance to BRAF inhibition in melanom...
- Here's to the crazy ones
- FDA rejects the Roche Immunogen T-DM1 accelerated ap...
- New potential targets in ovarian cancer?
- Inhibition of mutated, activated BRAF in metastatic ...
- NOTCH signaling and brain cancer
- Life is an adventure
- Nanoparticle drug delivery helps reduce tumour metas...
- More items from this source »
PharmaGossip
- Child’s Ordeal Shows Dangers of Antipsychotic Drugs ...
- Introducing Dr David Bransford's blog
- 21 Drugs Facing FDA Approval Decisions - TheStreet
- First and second generation antipsychotics in early ...
- Allergan Will Pay Fine, Plead Guilty to Misdemeanor ...
- AstraZeneca Given More Time to Settle 6,000 Seroquel...
- The Last Psychiatrist: The Most Important Article On...
- Roche coy on job cut reports | InPharm
- Fail
- Meet the Queen of “Preschool Depression” — and Her D...
- More items from this source »
Pharmalot
- American Heart Association, Avandia & Ghostwriting
- Another Japanese Drugmaker Buys Into Diet Pills
- Merck Blinks Over Plant Closings In The Netherlands
- Should The FDA Have Moved Faster On Meridia?
- JAMA Editor Catherine DeAngelis Is Leaving
- Merck Manager Charged With Insider Trading
- Pennsylvania Court Reinstates HRT Lawsuits
- Allergan Pays $600M To Settle Federal Botox Probe
- Pharma Job Cuts Fell In August: Survey
- Did Layoffs Help Hassan And Weldon Prosper?
- More items from this source »
Whydot Pharma
- Roche guidance won’t impact us…but it might impact o...
- Does Roche need to separate social media guidance in...
- Is the Roche social media guidance clear?
- Does it matter that Roche published its social media...
- Opinion poll on Roche social media guidance
- E-patients’ moments-of-truth are social
- Pharma social media? Or pharma engagement in social ...
- More items from this source »